Receive our newsletter – data, insights and analysis delivered to you
  1. Uncategorised
March 24, 2020

UQ receives more funding for Covid-19 vaccine

By Allie Nawrat

The regional government of Queensland and the federal Australian Government have pledged a total of $13m to University of Queensland (UQ) to support the development of its Covid-19 vaccine candidate.

UQ’s Covid-19 vaccine was one of the first three candidates to receive funding from the Norwegian non-profit Coalition for Epidemic Preparedness Innovations (CEPI) in January. This partnership was extended to include California-based Dynavax Technologies in March.

CEPI injected up to $10.6m into UQ’s molecular clamp technology, which is patented by university-linked UniQuest.

The university hopes this new injection of funds will help cut the timeline for an effective vaccine against the Covid-19 pandemic from 18 months to one year. The researchers hope to initiate clinical trials by July.

The university’s School of Chemistry and Molecular Biosciences senior research fellow Dr Keith Chappell added: “The containment procedures being put in place within Australia and internationally will slow the spread of the virus and we want to use that time as effectively as possible.

“Accelerating our work to find a safe and effective vaccine brings us a step closer to translating a fundamental research discovery through to the full scale manufacture for the global populace.”

Content from our partners
Extractables and leachables analysis in pharmaceutical quality control
How Hengst helped to keep Germany’s charity “star singers” shining

Related Companies

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU